Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study. [electronic resource]
Producer: 20020522Description: 320-31 p. digitalISSN:- 1369-7137
- Cholesterol -- blood
- Cholesterol, HDL -- blood
- Cholesterol, LDL -- blood
- Double-Blind Method
- Estradiol -- administration & dosage
- Estrogen Replacement Therapy
- Europe
- Female
- Fibrinogen -- drug effects
- Humans
- Lipoproteins -- blood
- Middle Aged
- Norethindrone -- administration & dosage
- Norethindrone Acetate
- Postmenopause
- Prospective Studies
- Raloxifene Hydrochloride -- administration & dosage
- Selective Estrogen Receptor Modulators -- administration & dosage
- Triglycerides -- blood
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.